[NDRA] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
14-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 36.52%
YoY- 7.24%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 0 0 0 0 287 0 326 -
PBT -2,658 -3,258 -3,414 -2,759 -909 -980 -541 30.35%
Tax -8 396 684 288 6 373 -34 -21.41%
NP -2,658 -3,258 -3,414 -2,759 -909 -980 -541 30.35%
Tax Rate - - - - - - - -
Total Cost 2,658 3,258 3,414 2,759 1,196 980 867 20.50%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 -316.69 0.00 -165.90 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -1.27 -2.73 -9.19 -14.05 -4.65 -5.02 -2.77 -12.17%
EPS Diluted -1.27 -2.73 -9.19 -14.05 -4.65 -5.02 -2.77 -12.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.